Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TRIFAST PLC Director's Dealing 2026

Apr 17, 2026

4723_dirs_2026-04-17_1c80e4c9-fa12-4dba-8b7d-ce33db327011.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7958A

Trifast PLC

17 April 2026

Trifast_col_blue

17 April 2026

Trifast plc

(the "Company")

Director/PDMR shareholding

The Company announces that on 16 April 2026, Iain Percival, Chief Executive Officer, acquired 4621 ordinary shares of 5 pence each in the Company ("Ordinary Shares"), at a price of 67.6p which were purchased under the Company's Dividend Re-Investment Plan. 

On 14 April 2026, Clive Watson, Senior Independent Non-Executive Director, acquired 973 ordinary shares of 5 pence each in the Company ("Ordinary Shares") at a price of 71.4p which were purchased under the Company's Dividend Re-Investment Plan. 

Following these transactions, Mr. Percival and Mr. Watson have a beneficial interest of 525,652 and 117,451 Ordinary Shares in the Company respectively.

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: +44 (0) 1825 769696

www.trifast.com

The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.

1.            

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Iain Percival

2.             

Reason for the notification

a.             

Position/status

Chief Executive Officer

b.             

Initial notification/Amendment

Initial notification

3.             

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.            

Name

Trifast plc

b.            

LEI

213800WFIVE6RWK3CR22

4.             

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.             

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.             

Nature of the transaction

Purchase of shares through the Dividend Re-Investment Plan

c.             

Price(s) and volume(s)

Price(s) Volume(s)
67.6p 4621

d.             

Aggregated information

·      Aggregated volume

·      Price

4621

67.6p

e.             

Date of the transaction

16 April 2026

f.             

Place of the transaction

London Stock Exchange, Main Market (XLON)

1.            

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Clive Watson

2.             

Reason for the notification

a.             

Position/status

Independent Non-Executive Director

b.             

Initial notification/Amendment

Initial notification

3.             

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.            

Name

Trifast plc

b.            

LEI

213800WFIVE6RWK3CR22

4.             

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.             

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.             

Nature of the transaction

Purchase of shares through the Dividend Re-Investment Plan

c.             

Price(s) and volume(s)

Price(s) Volume(s)
71.4p 973

d.             

Aggregated information

·      Aggregated volume

·      Price

973

71.4p

e.             

Date of the transaction

14 April 2026

f.             

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHKZGMDGVFGVZM